ID

34266

Description

The Norwegian Pancreas Transplantation (PTx) Study; ODM derived from: https://clinicaltrials.gov/show/NCT01957696

Link

https://clinicaltrials.gov/show/NCT01957696

Keywords

  1. 1/16/19 1/16/19 -
Copyright Holder

see on clinicaltrials.gov

Uploaded on

January 16, 2019

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Diabetes Mellitus NCT01957696

Eligibility Diabetes Mellitus NCT01957696

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
age ≥18 years
Description

ID.1

Data type

boolean

patients who receive a primary or secondary pancreas transplant, with or without a simultaneous kidney transplant (spk).
Description

ID.2

Data type

boolean

women who are of childbearing potential must have a negative serum pregnancy test at baseline.
Description

ID.3

Data type

boolean

operability has to be ascertained by preoperative examination, performed by nephrologist, transplant surgeon and anaesthesiologist.
Description

ID.4

Data type

boolean

signed and dated informed consent form.
Description

ID.5

Data type

boolean

Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
evidence of systemic infection
Description

ID.6

Data type

boolean

presence of unstable cardiovascular disease.
Description

ID.7

Data type

boolean

malignancy < 5 years prior to entry into the trial (with the exception of adequately treated basal cell or squamous cell carcinomas of the skin).
Description

ID.8

Data type

boolean

panel-reactive antibodies (pra) > 20% or the presence of donor-specific antigens (dsa).
Description

ID.9

Data type

boolean

any positive test for hbv, hbc or hiv.
Description

ID.10

Data type

boolean

Similar models

Eligibility Diabetes Mellitus NCT01957696

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
age ≥18 years
boolean
ID.2
Item
patients who receive a primary or secondary pancreas transplant, with or without a simultaneous kidney transplant (spk).
boolean
ID.3
Item
women who are of childbearing potential must have a negative serum pregnancy test at baseline.
boolean
ID.4
Item
operability has to be ascertained by preoperative examination, performed by nephrologist, transplant surgeon and anaesthesiologist.
boolean
ID.5
Item
signed and dated informed consent form.
boolean
Item Group
C0680251 (UMLS CUI)
ID.6
Item
evidence of systemic infection
boolean
ID.7
Item
presence of unstable cardiovascular disease.
boolean
ID.8
Item
malignancy < 5 years prior to entry into the trial (with the exception of adequately treated basal cell or squamous cell carcinomas of the skin).
boolean
ID.9
Item
panel-reactive antibodies (pra) > 20% or the presence of donor-specific antigens (dsa).
boolean
ID.10
Item
any positive test for hbv, hbc or hiv.
boolean

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial